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Abstract
Background: The RB1 gene was the first tumor suppressor gene cloned from humans by studying
genetic lesions in families with retinoblastoma. Children who inherit one defective copy of the RB1
gene have an increased susceptibility to retinoblastoma. Several years after the identification of the
human RB1 gene, a targeted deletion of Rb was generated in mice. Mice with one defective copy of
the Rb gene do not develop retinoblastoma. In this manuscript, we explore the different roles of
the Rb family in human and mouse retinal development in order to better understand the species-
specific difference in retinoblastoma susceptibility.
Results: We found that the Rb family of proteins (Rb, p107 and p130) are expressed in a dynamic
manner during mouse retinal development. The primary Rb family member expressed in
proliferating embryonic retinal progenitor cells in mice is p107, which is required for appropriate
cell cycle exit during retinogenesis. The primary Rb family member expressed in proliferating
postnatal retinal progenitor cells is Rb. p130 protein is expressed redundantly with Rb in
postmitotic cells of the inner nuclear layer and the ganglion cell layer of the mouse retina. When
Rb is inactivated in an acute or chronic manner during mouse retinal development, p107 is
upregulated in a compensatory manner. Similarly, when p107 is inactivated in the mouse retina, Rb
is upregulated. No changes in p130 expression were seen when p107, Rb or both were inactivated
in the developing mouse retina. In the human retina, RB1 was the primary family member expressed
throughout development. There was very little if any p107 expressed in the developing human
retina. In contrast to the developing mouse retina, when RB1 was acutely inactivated in the
developing human fetal retina, p107 was not upregulated in a compensatory manner.
Conclusion: We propose that intrinsic genetic compensation between Rb and p107 prevents
retinoblastoma in Rb- or p107-deficient mice, but this compensation does not occur in humans.
Together, these data suggest a model that explains why humans are susceptible to retinoblastoma
following RB1 loss, but mice require both Rb and p107 gene inactivation.
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Background
The timing of cell cycle exit is coordinated with cell-fate
specification and differentiation in the developing central
nervous system (CNS) to ensure that the appropriate
number of neurons and glia are generated in the correct
proportion. If too many neural progenitor cells exit the
cell cycle during the early stages of development, then the
overall number of cells is reduced, and the ratio of cell
types shifts [1,2].
Genetically engineered mice carrying targeted deletions of
tumor suppressor genes that regulate cell cycle progres-
sion have been used to study the coordination of prolifer-
ation and cell-fate specification during development.
Mice lacking the retinoblastoma susceptibility gene, Rb1
[3-5], were among the first characterized. In embryonic
day (E) 13.5 Rb-/- mouse embryos, ectopic mitosis was
observed outside the ventricular zone of the developing
hindbrain, and concurrent apoptosis was observed in the
region where postmitotic cells normally migrate and dif-
ferentiate [4,5]. In contrast, the E13.5 Rb-/- retina was
indistinguishable from E13.5 wild-type or Rb-hetero-
zygous retinas [3-6].
Lee and colleagues proposed that specific neuronal sub-
lineages have unique requirements for Rb during develop-
ment [5]. To explain the specific defects in neurogenesis in
Rb-deficient animals, Jacks and colleagues suggested that
other, closely related Rb proteins such as p107 play a
more prominent role in certain lineages [4]. For example,
tissues uniquely dependent on Rb (e.g., developing hind-
brain) may exhibit defects in Rb-/- embryos, but lineages
that are not (e.g., embryonic retina) appear normal in its
absence.
Although the Rb-deficient embryonic mouse retina devel-
ops normally up to E13.5, Rb may play an important role
at later stages of development [7]. Using Cre-expressing
retroviruses and a retinal progenitor-specific Cre trans-
genic mouse line (Chx10-Cre) mated to RbLox mice [8], we
previously showed that the retinal defects first identified
by Maandag and colleagues reflect a cell-autonomous
requirement for Rb at specific developmental stages in ret-
inal progenitor cells and rod photoreceptors [6,9]. Two
other groups published similar findings using Cre trans-
genic mouse lines with broader expression in the retina
[10] and throughout the CNS [11]. Other phenotypes
characterized in Rb-/- embryos were recently found to be
secondary non-cell-autonomous effects caused by
changes in extraembryonic tissues [12].
Analysis of mice carrying targeted deletions of p107 and
Rb (Rb+/-; p107-/-) indicated that p107 is important for ret-
inal development [13]. Mild retinal dysplasia was
observed in the Rb+/-; p107-/- mice at 4 to 6 months of age,
and histologic analysis of postnatal day (P) 4 retinas sug-
gested that dysplasia originated during development [13].
Subsequent studies using chimeric mice generated from
Rb-/-; p107-/- embryonic stem cells [14] and those involv-
ing conditional inactivation of Rb in the developing retina
[10,15] or CNS [11] have not elucidated individual roles
of Rb or p107 in retinogenesis.
When progenitor cell proliferation is disrupted during
development, secondary effects on cell-fate specification
and differentiation are likely to occur [1,2]. Therefore, dis-
tinguishing the roles of Rb and p107 in proliferation from
those in cell-fate specification is a major challenge. In
addition, elucidating the cell-autonomous and non-cell-
autonomous [12] roles of the Rb family during develop-
ment can be challenging [16]. Moreover, as several inves-
tigators have proposed [3-5,13,17], individual Rb
proteins are likely to have both unique and overlapping
roles during development, thereby making it difficult to
identify their individual contributions. Compensation
and redundancy can further complicate analyses and
obscure the individual roles of Rb proteins during devel-
opment [2,18,19]. Interestingly, the response to acute
inactivation of Rb in mouse embryonic fibroblasts (MEFs)
differs from that seen when Rb is inactivated in a chronic
manner [20]. This finding increases the complexity of the
genetic analyses of Rb family function in vivo.
Relatively little is known about the expression or the role
of the Rb family during human fetal retinal development.
Therefore, we do not know if Rb, p107 and p130 are play-
ing different roles in the developing human and mouse
retinas or if cell cycle regulation through the Rb family is
evolutionarily conserved.
In this study, we used genetic tools (replication-incompe-
tent retroviruses, in vivo electroporation, and SiRNA anal-
yses) combined with cell cycle analysis to investigate the
individual cell-autonomous roles of Rb and p107 in the
developing retina. We also sought to compare Rb family
expression and intrinsic genetic compensation during ret-
inal development in mice and humans to explain why
humans are susceptible to retinoblastoma following RB1
inactivation, but mice are not.
Results
Expression of the Rb family during mouse retinal 
development
Previous genetic studies have established that inactivation
of Rb and p107 or Rb and p130 in the developing mouse
retina can lead to retinoblastoma [6,10,11,14,15,21].
However, it is not known if Rb, p107 and p130 are
expressed redundantly in the developing mouse retina or
if intrinsic genetic compensation by p107, p130 or both
prevents retinoblastoma in Rb-deficient mice. As a firstBMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
Page 3 of 21
(page number not for citation purposes)
step toward distinguishing between these two possibili-
ties, we analyzed the expression of Rb, p107 and p130
over seven stages of mouse retinal histogenesis. Real-time
RT-PCR and immunoblot analyses of E14.5 to P0 mice
indicated that p107 is the primary Rb protein expressed in
proliferating retinal progenitor cells (Fig. 1A, D). As the
levels of p107 mRNA and protein decreased at P0, those
of Rb and p130 increased (Fig. 1B–D) [6]. However, a low
level of Rb was detected in a subset of embryonic retinal
progenitor cells and newly postmitotic (transition) cells at
the basal and apical surfaces of the developing inner neu-
roblastic layer (INBL) (Fig. 1E–K) [6].
Dynamic expression of the Rb family during mouse retinal development Figure 1
Dynamic expression of the Rb family during mouse retinal development. (A-C) Real-time PCR analysis of p107, Rb 
and p130 was done at seven stages of mouse retinal development. Data sets of three retinas per stage were analyzed twice, 
normalized to Gapdh and averaged. The standard deviations were within 5% of the mean. (D) Immunoblot analysis was done at 
five stages of mouse retinal development. For negative controls, MEF lysates prepared from knockout embryos were used. 
Positive controls were taken from 293T cells ectopically expressing the full-length cDNAs. Data were normalized to actin. (E-
I) Immunofluorescent detection of Rb (green) in E14.5 and E17.5 retinas was overlaid on the nuclear counterstain (red). (J) 
Radioactive in situ hybridization analysis of Rb (blue silver grains) levels at P0 demonstrated broad expression in the onbl and 
inbl. This finding was consistent with immunofluorescent detection (green) of the protein (K). (L-O) Immunofluorescent 
detection of p107 (green) in E14.5 and E17.5 retinas was overlaid on the nuclear counterstain (red). (P) Radioactive in situ 
hybridization for p107 (blue silver grains) at E17.5 demonstrated broad expression in the onbl and little expression at P3 (Q). 
(R-T) Immunofluorescence of p130 at P12 (green) was overlaid on the nuclear counterstain (red). (U) Expression of p130 
mRNA at P12 was consistent with the protein expression data. (V) Summary of the dynamic expression of the Rb family dur-
ing retinal development. Abbreviations: GCL, ganglion cell layer; inbl, inner neuroblastic layer; INL, inner nuclear layer; MEF, 
mouse embryonic fibroblast; onbl, outer neuroblastic layer; ONL, outer nuclear layer. Scale bars: E, G, I, N, O and T, 10 µm; J, 
K, L, M, P, R and S, 25 µm.BMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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The p107 mRNA and protein were restricted to proliferat-
ing retinal progenitor cells in the outer neuroblastic layer
(ONBL) (Fig. 1L–Q), and p130 mRNA and protein were
restricted to a subset of postnatal retinal progenitor cells,
postmitotic neurons and glia in the inner nuclear layer
(INL) and ganglion cell layer (GCL) during the final stages
of retinal histogenesis (Fig. 1R–U and data not shown)
[6]. These data indicated that the embryonic retinal pro-
genitor cells primarily express p107 (Fig. 1V), which is
consistent with a lack of any retinal phenotype in Rb-/-
Expression of the Rb family during the cell cycle Figure 2
Expression of the Rb family during the cell cycle. (A-D) The E14.5 retinal explants were maintain in culture in the pres-
ence of [3H]thy for 1 h, washed and then maintained in culture for different periods. Dissociated retinas (dapi in A) were then 
immunostained for p107 (red in B) and overlaid with autoradiographic emulsion to detect the [3H]thy (C). The proportion of 
p107+ cells was then scored (250 cells in duplicate), and normalized data were plotted (D). The peak level of p107 was 
detected after 8 h of exposure, which coincided with the G2 and M phases of the cell cycle, and declined at 24 h, which coin-
cided with the G1/G0 phase. (E-H) Similar experiments were done using P0 retinal explants and in P2 retinal explants (I-L). 
(H) The proportion of [3H]thy-labeled Rb+ cells from P0 retinal explants was high during 0 to 4 h of exposure (S, G2) and sub-
sequently declined. (L) The level of [3H]thy-labeled p130+ cells in P2 retinal explants was low during the first 4 h (S, G2), 
peaked at 8 and 16 h (M phase) and then declined during G1/G0. Similar data for p27 are plotted as an internal reference for 
cell cycle phase estimates. Scale bars: A, E and I, 10 µm.BMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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Reciprocal compensation after Rb or p107 inactivation Figure 3
Reciprocal compensation after Rb or p107 inactivation. (A) Real-time PCR analysis of Rb expression in retinas from 
three developmental stages of p107-deficient or wild-type mice. At E13.5, Rb was upregulated. Analysis was done in triplicate 
samples analyzed in duplicate. (B) In a similar experiment, p107 expression was analyzed in Rb-deficient retinas. Due to the 
embryonic lethality of deleting Rb, cultured retinas were used for the later stages; p107 was upregulated in a compensatory 
manner. (C) A summary of the changes in Rb family gene expression after Rb or p107 inactivation. (D) E13.5 p107-deficient 
retinas were labeled with [3H]thy for 4 h and immunostained for Rb expression (red). (E) In a similar experiment, cultured Rb-
deficient retinas were labeled for p107 expression. (F, G) In the absence of Rb in Chx10-Cre;RbLox/- P12 retinas, rod photore-
ceptors failed to form, and chromatin failed to condense in the ONL (arrow). (H) Chromatin (arrow) in rod photoreceptors 
normally condenses during differentiation. (I) In the absence of Rb, rods remained immature with diffuse chromatin (arrow). 
(J) These defects in cell-fate specification also caused defects in synaptogenesis of horizontal cells (arrows); with processes 
extending apically into the ONL. (K-N) Wild-type and Rb-deficient E13.5 retinas were immunostained with an antibody against 
Brn3b (red), a ganglion cell marker. Brn3b was distributed across the retina (green nuclear stain overlay) and was indistinguish-
able in the presence or absence of Rb. (O-R) Wild-type and p107-deficient E15.5 retinas were immunostained for p57Kip2 
(red), which was expressed in a subset of retinal progenitor cells and newly postmitotic amacrine cells. (S) PSD95 (red) was 
expressed in the OPL and was normally distributed in the absence of p107. (T) Amacrine cells stained with tyrosine hydroxy-
lase were also distributed normally. (U, V) Cone photoreceptors, (W, X) calretinin+ amacrine cells and (Y, Z) amacrine cells 
and horizontal cells were distributed normally in the p107-knockout retinas. Abbreviations: DIC, days in culture; INL, inner 
nuclear layer; IPL, inner plexiform layer; ONL, outer nuclear layer; OPL, outer plexiform layer. Scale bars: B, D, F, H, L, N, P, T 
and U, 10 µm; I and J, 25 µm.BMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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embryonic retinas. In the postnatal retina and in differen-
tiated neurons and glia of the INL and GCL, Rb and p130
were expressed redundantly (Fig. 1V). Rb is the only fam-
ily member expressed in rod photoreceptors, a finding
that is consistent with its unique role in the development
of this neuronal cell type [6]. Together, these data suggest
that Rb and p107 are expressed in a largely nonoverlap-
ping pattern during mouse retinal development, which
raises the possibility of compensation by p107 when Rb is
inactivated. Moreover, Rb and p130 expression overlaps,
which supports the idea that these proteins play redun-
dant roles in a subset of retinal neurons.
Expression of the Rb family during the cell cycle in retinal 
progenitor cells
Beyond determining when and where each Rb family
member is expressed during retinal development, it is
important to determine when during the cell cycle Rb,
p107 and p130 are expressed. These data may help to elu-
cidate their normal roles during development. For exam-
ple, if a family member is only expressed in proliferating
retinal progenitor cells, then that protein is unlikely to
play a role in neuronal differentiation. It has been well
established in a variety of culture systems that Rb, p107
and p130 are expressed during different phases of the cell
cycle. To directly determine when during the cell cycle
these proteins are expressed throughout retinal develop-
ment, we scored the colocalization of [3H]thymidine
([3H]thy) with p107 (Fig. 2A–D), Rb (Fig. 2E–H) or p130
(Fig. 2I–L) at five time points during four stages of devel-
opment [2,22,23]. The expression of p27Kip1 has been
characterized previously [22], and a parallel set of samples
was analyzed for p27Kip1 expression to serve as an internal
control. The p27Kip1 protein is upregulated as cells exit the
cell cycle throughout retinal development, and the kinet-
ics are different at E14.5, P0 and P2, because the length of
the retinal progenitor cell cycle increases during retino-
genesis [24]. At E14.5, 62% to 77% of proliferating cells
expressed p107, and 4% to 6% expressed Rb (see Addi-
tional file 1). The 36% reduction in the proportion of
p107+ cells at the 24-h time point in E14.5 retinas was
consistent with the previous finding that 20% to 25% of
rat retinal progenitor cells exit the cell cycle at a similar
stage [22,24,25].
At P0, 76% to 87% of proliferating retinal progenitor cells
expressed Rb (see Additional file 1; Fig. 2E–H), and the
remaining cells expressed p107 (data not shown). Unlike
p107+ cells, Rb+ P0 retinal progenitor cells continued to
express Rb after they exited the cell cycle (compare Fig. 2H
and 2D). In the P2 retina, the level of p130 peaked in the
late G2/early M phase of the cell cycle and persisted into
G1/G0 (see Additional file 1; Fig. 2I–L). Many cells down-
regulated p130 as they exited the cell cycle; this finding
was consistent with the birth of rod photoreceptors (80%
of the total cell population in the retina), which do not
express p130 (Fig. 1R–U). Results from the [3H]thy pulse-
labeling experiment combined with those from the
immunostaining, real-time RT-PCR, in situ hybridization
and immunoblot studies (Fig. 1) suggested that p107 is
expressed primarily in retinal progenitor cells during
embryonic retinal development; Rb is expressed in both
retinal progenitor cells and postmitotic neurons and glia
in the postnatal retina, and p130 is expressed in cells exit-
ing the cell cycle during the late stages of retinal develop-
ment. These data help us to further refine the possible
compensatory and redundant roles of Rb, p107 and p130
during retinal development. Specifically, Rb and p130
may play redundant roles in postnatal retinal progenitor
cells and postmitotic differentiated neurons of the INL
and GCL. Rb and p107 are both expressed in proliferating
retinal progenitor cells, albeit at different stages of devel-
opment. Inactivation of either Rb or p107 in proliferating
retinal progenitor cells may lead to compensatory upreg-
ulation of the other family member.
Reciprocal compensation between Rb and p107 in mouse 
retinal progenitor cells
To directly determine whether Rb family members com-
pensate for each other in the developing retina, we iso-
lated RNA from p107-/-, p107+/-, p107+/+, Rb-/-, Rb+/- and
Rb+/+ retinas at E13.5, P0 and P6 for real-time PCR analy-
sis. In E13.5 retinas lacking p107, Rb mRNA was upregu-
lated in a compensatory manner (Fig. 3A). Similarly, in
postnatal retinas lacking Rb, p107 mRNA was upregulated
(Fig. 3B, C). The expression of p130 did not change signif-
icantly in any of the samples (data not shown).
Next, we tested whether the Rb and p107 proteins were
also upregulated in a compensatory manner in proliferat-
ing retinal progenitor cells. Retinas were pulse-labeled
with [3H]thy for 1 h, dissociated and immunostained for
Rb and p107 (Fig. 3D, E). The mean proportion of Rb+
cells in the E13.5 p107-/- retinas (54% ± 6%) was signifi-
cantly higher than that in stage-matched wild-type retinas
(4% ± 1.2%; p < 0.001). The mean proportion of p107+
cells in the P2 Rb-/- retinas (7.3% ± 1.1%) was also signif-
icantly higher than that in age-matched wild-type retina
(0.3% ± 0.2%; p < 0.005). The proportion of p107+ cells
was lower than that of Rb+ cells, because there are fewer
proliferating retinal progenitor cells at P2 than at E13.5
[24].
We have shown previously that Rb is required cell auton-
omously for the development of postmitotic rod photore-
ceptors [6,9]. To test whether p107 compensates for Rb in
regulating the development of these postmitotic neurons,
we performed electron microscopic (EM) analysis of
Chx10-Cre;RbLox/- retinas. One early morphologic feature
of rod photoreceptor differentiation is chromatin conden-BMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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Acute inactivation of RB1 in human fetal retinas Figure 4
Acute inactivation of RB1 in human fetal retinas. (A-D) Representative in situ hybridization of fetal week 16 human ret-
inas with DIG-labeled probes (A, C) and radioactively labeled probes (B, D) shows that RB1 is the major RB family member 
expressed in proliferating retinal progenitor cells during development. (E-G) Immunofluorescent detection of RB1 (green) in 
fetal week 16 human retinas confirmed that the protein is expressed in the same pattern as the mRNA. (H) Real-time RT-PCR 
analysis using TaqMan® probes for RB1 demonstrated that the expression level does not dramatically change over the course of 
retinal histogenesis. Data sets were analyzed twice, normalized to Gapdh expression and averaged. (I) The sclera and pig-
mented epithelium were positive controls for p107 expression. (J) To inactivate RB1 in human fetal retinas, primary tissue was 
square-wave electroporated with a plasmid that encoded an siRNA to RB1 and a venus-YFP reporter gene. Retinas were then 
maintained in culture for several days and analyzed for compensation by p107. (K) COS cells transfected with the RB1 SiRNA 
vector shown in (J) showed a 21-fold reduction in the level of RB1 protein. Densitometry of normalized values for RB1 is 
shown in the lower portion of panel (K). (L, M) The venus-YFP+ retinal cells that were also [3H]thy+ downregulated RB1 but 
did not upregulate p107. The negative control SiRNA shown in (M) is the Gapdh SiRNA, but other nonspecific siRNAs gave 
similar results. The positive control samples are retinas that were square-wave electroporated with a plasmid expressing RB1, 
p107 or p130 and processed side-by-side with the SiRNA samples. Abbreviations: GCL, ganglion cell layer; inbl, inner neu-
roblastic layer; onbl, outer neuroblastic layer; PE, pigmented epithelium. Scale bars: G and L, 10 µm; B, D and E, 25 µm.BMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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sation (Fig. 3F–H). In the absence of Rb, p107 was upreg-
ulated, but the cells fated to differentiate into rod
photoreceptors, failed to condense their chromatin (Fig.
3I) and formed defective synapses in the outer plexiform
layer (OPL) (Fig. 3J). These data suggest that the p107
compensation in the postnatal Rb-deficient mouse retina
(Fig. 3B, C) helped to prevent deregulated proliferation
but did not rescue the rod differentiation phenotype [6,9].
Rb is also expressed in a small subset of embryonic retinal
progenitor cells (Fig. 1, 2; see Additional file 1), and sub-
tle defects may occur in Rb-/- embryonic retinas if p107
does not compensate at this stage of development. We
immunostained Rb-/-, Rb+/- and Rb+/+ retinas at E13.5 with
antibodies to several cell cycle proteins (p27Kip1, p57Kip2,
cyclin D1, cyclin D3) and markers of differentiated cell
types (Brn3b, GAP43, syntaxin, calbindin, cone arrestin).
There was no difference among the three genotypes, in
either the distribution or proportion of cells expressing
any of these proliferation or differentiation markers (Fig.
3K–R and data not shown).
To determine if the compensation by Rb in p107-deficient
retinas (Fig. 3A, C) prevented any defects in retinal pro-
genitor cell proliferation, differentiation or both, we ana-
lyzed proliferation (BrdU labeling), apoptosis (TUNEL
assay), cell-fate specification and neuronal differentiation
(35 antibodies, see Methods) in p107-/-, p107+/- and p107+/
+ retinas at E13.5, E15.5, P0, P3, P6 and P12. There was no
significant difference among the genotypes at any stage
examined (Fig. 3E–H). Even in vivo lineage studies using
a replication-incompetent retrovirus in p107-/-, p107+/- and
p107+/+ retinas revealed no defect in proliferation, sur-
vival, cell-fate specification or differentiation (Schweers
and Dyer, in preparation). Together, these genetic analy-
ses suggest that reciprocal compensation between Rb and
p107 in retinal progenitor cells prevents deregulated pro-
liferation during development. The p107 protein cannot
compensate for Rb in postmitotic differentiating rods, and
there was no evidence for p130 compensation in either
Rb- or p107-deficient retinas at any stage of development.
p107 compensation does not occur in the human fetal 
retina after RB1 inactivation
RB1 inactivation is sufficient for retinoblastoma initiation
in humans, which suggests that p107 does not compen-
sate or play a redundant role when RB1 is lost in human
fetal retinas. To begin to address this question, we charac-
terized the expression of the Rb family during human fetal
retinal development by performing immunostaining, in
situ hybridization and real-time RT-PCR analyses (Fig.
4A–H). Primary human fetal retinas from fetal weeks 9,
10, 11, 12, 14, 16, 18, 20 and 23 were analyzed; these
stages of human fetal development correspond to the
entire period of retinal progenitor cell proliferation (E14-
P10) in the mouse [26]. RB1 is the primary family mem-
ber expressed in proliferating retinal progenitor cells
throughout human retinal development. Little p107
expression was detected by immunostaining, real-time
RT-PCR or in situ hybridization analyses (Fig. 4C, D). An
internal positive control for these expression studies was
the surrounding sclera and pigmented epithelium that
expressed high levels of p107 (Fig. 4I). During the late
stages of retinal development, p130 was expressed in the
retina in a pattern similar to that seen in mouse retinal
development (data not shown).
To test if p107 compensation occurs when RB1 is inacti-
vated, we performed square-wave electroporation to
introduce the RB1 SiRNA and a venus-YFP reporter gene
into human fetal week 11 retinas (Fig. 4J). The SiRNA
knocked down RB1 protein expression by approximately
20 fold (Fig. 4K). An SiRNA to Gapdh and a scrambled RB1
SiRNA were used as negative controls. Retinas were main-
tained in culture for several days by using a procedure we
optimized for mouse and primate fetal retinas (see Meth-
ods). Retinal progenitor cells proliferated normally with
no appreciable cell death for at least 5 days while in this
culture system (see Additional file 2). At several time
points after electroporation, we labeled proliferating reti-
nal progenitor cells with [3H]thy, dissociated the retinas,
plated the cells on glass slides and immunostained them
for RB1, p107 and p130 (Fig. 4L and data not shown). By
scoring the expression of the Rb family in venus-YFP+ cells
that were also [3H]thy+, we found that RB1 was downreg-
ulated by the SiRNA 48 h after electroporation, but there
was no compensation by p107 or p130 (Fig. 4M). An
identical experiment carried out on fetal week 14 retinas
gave similar results (data not shown). As positive controls
for RB1, p107 and p130 immunostaining, we electropo-
rated parallel cultures with a plasmid expressing these
proteins (Fig. 4M). The expression data combined with
that from the RB1 gene inactivation studies in primary
human fetal retinas suggested that p107 is not normally
expressed in the developing human retina, and it cannot
compensate for RB1 loss in this tissue.
Acute inactivation of Rb in the developing mouse retina
Compensation of p107 in MEFs depends on whether Rb is
inactivated in an acute or chronic manner [20]. Our stud-
ies on Rb-knockout retinas including Chx10-Cre;RbLox/- ret-
inas showed that p107 was upregulated in a
compensatory manner after chronic Rb inactivation in the
retina. To determine whether this result occurs after acute
Rb gene inactivation in the developing retina in vivo, we
introduced a Cre-expressing plasmid (pCre-vYFP) into the
eyes of newborn RbLox/- mice (Fig. 5A). Real-time RT-PCR
analysis of purified retinal cell populations (Fig. 5B–G) in
which  Rb  was acutely inactivated showed that p107
mRNA was upregulated (Fig. 5H), as was seen afterBMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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Acute inactivation of Rb in the developing mouse retina Figure 5
Acute inactivation of Rb in the developing mouse retina. (A-G) In vivo or in vitro square-wave electroporation and 
purification of cells with acute Rb inactivation. (C) A retina after electroporation is shown. (D-G) Dissociated cells before and 
after FACS purification are shown. (H) Real-time PCR analysis of YFP+ purified cells after acute Rb inactivation; each sample 
was analyzed in duplicate and normalized to Gapdh and Gpi1. (I, J) Immunostaining of purified cells after Rb inactivation. (K-N) 
To determine if retinal progenitor cells continue to divide after acute Rb inactivation, we scored the proportion of [3H]thy-
labeled BrdU+ cells. An example of a double-positive cell is shown in (K). (L) A significant proportion of progenitor cells was 
sensitive to deregulated proliferation after acute Rb inactivation, as indicated by the increase in double-positive cells. Data are 
normalized to account for the fraction of cells labeled with BrdU during a 1-h pulse. (M) The proportion of retinal progenitor 
cells that continue to divide after acute Rb inactivation is shown in the venus-Cre, YFP+ column. (N) Real-time PCR analysis of 
cell samples used in (L) and (M) revealed a significant increase in the expression of p107 and retinal progenitor cell markers 
Sfrp1, Erdr1 and Chx10 after acute Rb inactivation. Scale bars: C, D, F, I and J, 10 µm.BMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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Haploinsufficiency of p107 in the developing mouse retina Figure 6
Haploinsufficiency of p107 in the developing mouse retina. Immunostaining of P30 Rb+/-; p107-/- retinas in the region of 
the retinal dysplasia. (A, B) Antibodies against calbindin were used to identify horizontal cells; (C, D) those against Chx10, 
bipolar cells; (F, G) those against glutamine synthetase, Müller glia; and (H, I) those against bassoon, synapses in the OPL and 
IPL. (E) EM analysis of the P30 Rb+/-; p107-/- retinas showing the OPL with normal organization of synaptic connections in con-
trast to the Rb-deficient retinas. (J-T) Immunostaining of P14 Chx10-Cre;RbLox/-; p107+/- retinas in the region of Cre-mediated Rb 
inactivation using antibodies to OPL synapses (PSD-95, J-M), horizontal cells (calbindin, O, P), amacrine/progenitor cells (Pax6, 
Q, R), and reactive Müller glia (GFAP, S, T). (N) EM analysis of the P14 Chx10-Cre;RbLox/-; p107+/- retinas showing the OPL 
with disrupted synaptic connections and an apical horizontal process (arrows). (U-Y) To determine if there are any ectopically 
dividing cells in Rb+/-; p107-/-, Rb-/-; p107+/- or Rb-/-; p107-/- retinas at E14.5, P0, P6, P12 and P30, we labeled retinas with [3H]thy 
and BrdU for 1 h and then dissociated and immunostained the cells with antibodies against 12 markers of different retinal cell 
types. BrdU and [3H]thy always colocalized. (W) The only markers that colocalized with [3H]thy were amacrine/progenitor 
cell markers Pax6 and syntaxin and bipolar/progenitor cell marker Chx10. There were also some reactive Müller glia, as indi-
cated by GFAP, that incorporated [3H]thy. Ectopic proliferation was more prevalent in the double-knockout retinas than in the 
other genotypes. Each bar is the average of triplicate samples scored in duplicate. (X, Y) Real-time PCR analysis demonstrated 
that throughout development there were more progenitor cell markers such as Cdk2 and Sfrp1 expressed in the double-
knockout and Rb-/-; p107+/- retinas. Abbreviations: GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear 
layer; OPL, outer plexiform layer. Scale bars: B, D, G, I, K, M, P, Q, T, U and V, 10 µm.BMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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chronic Rb gene inactivation in the developing retina (Fig.
3). There was little change in p130 expression (Fig. 5H).
Next, we determined whether acute inactivation of Rb
altered rod development. Real-time RT-PCR analysis of
RNA samples indicated that the early photoreceptor genes
Nrl and Nr2e3 were downregulated, as were several other
photoreceptor-specific genes (Fig. 5H and data not
shown). The cells that did not differentiate into photore-
ceptors resembled progenitor cells, as indicated by the
increased expression of Eya2 and Fgf15 (Fig. 5H) [27]. To
further verify these developmental defects, we immunos-
tained the purified cells that had undergone acute Rb inac-
tivation and compared them to the control cells (Fig. 5I,
J). Those data were consistent with real-time PCR data
showing that acute inactivation of Rb not only leads to a
compensatory increase in p107 expression, but also dis-
rupts rod development. Results of experiments in which
p107 was acutely inactivated in wild-type E14.5 retinas by
using an siRNA to p107 [20] were similar to those in the
p107-knockout retinas, i.e., Rb was upregulated in a com-
pensatory manner (data not shown).
Proliferating cells and nondividing or quiescent MEFs
exhibit differences in the timing of their compensatory
upregulation of p107 after Rb inactivation [20]. To test for
differences in compensation in proliferating retinal pro-
genitor cells and transition cells [28] in the developing ret-
ina, we acutely inactivated Rb  at P3. Even though the
majority (~ 95%) of cells in the P3 retina are postmitotic
[24], a disproportionate number of proliferating retinal
progenitor cells (42% ± 5.5%) underwent ectopic rounds
of cell division (Fig. 5K, L; see Additional file 3). Retinal
progenitor cells and transition cells were distinguished by
BrdU labeling prior to electroporation (Fig. 5A). This find-
ing suggests that retinal progenitor cells in which Rb has
been acutely inactivated are susceptible to deregulated
proliferation. A similar experiment in which all proliferat-
ing retinal progenitor cells in the P3 retina were labeled
with [3H]thy for 24 h prior to acute Rb  inactivation
showed the same result (Fig. 5M). Specifically, even
though retinal progenitor cells comprise only 7% of the
total cell population at P3, they comprised 74% ± 4% of
the cells that continued to divide after acute Rb inactiva-
tion (Fig. 5M). Real-time RT-PCR analysis of the samples
demonstrated that p107 was upregulated in a compensa-
tory manner and that retinal progenitor cell genes such as
Sfrp1, Erdr1 and Chx10 were also upregulated (Fig. 5N).
To test if p107 compensation after acute Rb inactivation
prevents deregulated proliferation, we acutely inactivated
p107 by using a previously characterized SiRNA [20] in
retinal cells in which Rb was chronically inactivated. We
found that proliferation significantly increased from 18%
± 1.9% to 34% ± 1.9% (p = 0.013) after acute p107 inacti-
vation (see Additional file 4). Moreover, the cells that con-
tinued to divide expressed retinal progenitor cell markers
Chx10, Pax6 and syntaxin and were BrdU+ retinal progen-
itor cells at the time of p107 inactivation (see Additional
file 4). Together, these data support the idea that p107
compensation is important for preventing deregulated
proliferation in retinal progenitor cells whether Rb is inac-
tivated in an acute or chronic manner.
Haploinsufficiency of p107 in the absence of Rb
Having shown that reciprocal compensation between Rb
and p107 in the developing retina prevents deregulated
proliferation of retinal progenitor cells, we tested whether
a single copy of Rb was sufficient to compensate for p107
deficiency and whether a single copy of p107 was suffi-
cient to compensate for Rb deficiency. Immunostaining of
Rb+/-; p107-/- retinas between P6 and P30 confirmed the
presence of minor focal retinal dysplasia, as reported pre-
viously [13]. The laminar structure and synaptogenesis
outside the regions of focal dysplasia were not substan-
tially disrupted (Fig. 6A–I and data not shown), as con-
firmed by EM analysis of the OPL (Fig. 6E). In addition,
EM analysis confirmed that rod photoreceptors [6] and
horizontal cells [9] form normally with just one copy of
Rb and no p107 (Fig. 6E). Even in the regions of the most
severe dysplasia (Fig. 6A–I), cells were in their appropriate
cellular layers, and synaptic markers were present in the
corresponding plexiform layer sublaminae. EM analysis
suggests that these focal dysplastic lesions are not formed
by preneoplastic retinoblastoma cells. That is, there is no
evidence for immature tumor cells localized to the
lesions.
In contrast to the Rb+/-; p107-/- retinas, the Chx10-Cre;RbLox/
-; p107+/- retinas exhibited much more severe developmen-
tal defects. Immunostaining revealed deregulated prolifer-
ation and lamination in an apical-basal mosaic pattern
that was consistent with the expression of Cre from the
Chx10 promoter of the Chx10-Cre transgene [9,29]. Rod
photoreceptors were not completely lost due to the
mosaic pattern of gene inactivation by the Chx10-Cre
allele [29]. Defects in OPL synaptogenesis (Fig. 6J–T) were
confirmed by EM analysis of P43 Chx10-Cre;RbLox/-; p107+/
- retinas (Fig. 6N). Müller glia showed upregulated expres-
sion of GFAP, which is a marker of reactive gliosis (Fig. 6S,
T); however, GFAP expression was not detectable in
Müller glia of the Rb+/-; p107-/- retinas.
To quantify the proportion and types of cells that were
proliferating in Rb+/-; p107-/-, Rb-/-; p107+/- and Rb-/-; p107-/
- retinas during development, we labeled P0, P6, P12 and
P30 retinas with [3H]thy for 1 h, dissociated the retinas
and immunostained the cells with antibodies that recog-
nized each of the retinal cell types (see Additional files
5,6,7,8). Few (if any) of the cells expressing differentiationBMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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Retinal progenitor cells continue to proliferate throughout development in the absence of Rb and p107 Figure 7
Retinal progenitor cells continue to proliferate throughout development in the absence of Rb and p107. (A-T) 
Immunostaining of P30 Chx10-Cre;RbLox/-; p107-/- retinas by using antibodies against (A-D) BrdU to identify ectopically dividing 
cells; (E-H) calbindin, horizontal cells and Chx10, bipolar/progenitor cells; (M-P) GFAP, reactive Müller glia; (Q, R) cone 
arrestin, cone photoreceptors and (S, T) Pax6, amacrine/progenitor cells. (U, V) Electron micrographs showing that most 
retinal structures are disrupted in the absence of Rb and p107 and that continued proliferation eventually leads to retinoblast-
oma. (W-Z) Newborn RbLox/Lox; p107-/- mice were injected with a retrovirus expressing Cre (LIA-Cre), and 3 weeks later, the 
retinas were sectioned and stained for alkaline phosphatase expression to identify the neurons that had lost Rb and p107. Ama-
crine cells (W) and bipolar cells (X) formed normally in the absence of Rb and p107. Rod photoreceptors (Y) failed to form 
normally. There were also several clones that spanned the INL or INL and ONL, which was indicative of hyperproliferation 
(Z). Similar experiments were carried out in E17.5 retinal explants by using a Cre-expressing retrovirus that also expresses 
nuclear LacZ (AA). These clones can readily be scored for cell number to determine if loss of Rb and p107 leads to deregu-
lated proliferation. Abbreviations: GCL, ganglion cell layer; INL, inner nuclear layer; olm, outer limiting membrane; ONL, 
outer nuclear layer. Scale bars: B, D, F, H, J, L, N, P, R, T and W-AA, 10 µm.BMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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markers such as recoverin (photoreceptors), cone arrestin
(cones) or PKCα (bipolar cells) incorporated [3H]thy (Fig.
6U–W; see Additional files 5,6,7,8). Primarily, cells
expressing progenitor cell markers (see Discussion) such
as syntaxin, Pax6 or Chx10 incorporated [3H]thy (Fig.
6U–W; see Additional files 5,6,7,8). A small proportion of
Müller glia also incorporated [3H]thy, a finding that was
consistent with reactive gliosis-associated proliferation
(Fig. 6S, T) [30]. The overall distribution of cell types was
not significantly altered in Rb+/-; p107-/- retinas (see Addi-
tional files 5,6,7,8), but as expected, the number of rods
was reduced in Chx10-Cre;RbLox/-; p107+/- retinas (see Addi-
tional files 5,6,7,8).
TUNEL assay results revealed no difference in the propor-
tion of apoptotic cells in Rb+/-; p107-/- retinas and that of
their wild-type littermates. The number of apoptotic cells
in Chx10-Cre;RbLox/-; p107+/- retinas was slightly higher
at P12 and P30, which corresponded to the stages of
increased proliferation (see Additional files 5,6,7,8). Real-
time RT-PCR analysis revealed increased expression of the
retinal progenitor cell genes Cdk2 (Fig. 6X) and Sfrp2 (Fig.
6Y). Together, these data suggest that one copy of Rb in
Rb+/-; p107-/- retinas is sufficient for much of retinal
development (with the exception of minor focal dyspla-
sia), but one copy of p107 in Chx10-Cre;RbLox/-; p107+/
- retinas is haploinsufficient to regulate proliferation. Spe-
cifically, in retinal progenitor cells, two copies of the p107
gene are required to compensate for loss of Rb, but only
one copy of Rb is required to compensate for loss of p107.
Deregulated proliferation in Rb;p107-deficient retinal 
progenitor cells
It has been shown previously that retinoblastoma forms
in Rb;p107-deficient retinas [10,11,14,15]. Therefore, we
propose that reciprocal compensation between Rb and
p107 in retinal progenitor cells prevents retinoblastoma
in mice. If this is true, then we predict that retinal progen-
itor cells will continue to divide throughout development
(E14-P30) in Rb;p107-deficient retinas. This is precisely
what we found (Fig. 7A–D; see Additional files 5,6,7,8).
The proliferating cells were detected in a mosaic pattern,
which was consistent with Rb inactivation by the Chx10-
Cre transgene (Fig. 7A–D) [9,29]. These immature prolif-
erating cells disrupted synaptogenesis in the OPL (Fig.
7E–H) and expressed the progenitor cell markers syntaxin,
Pax6 and Chx10 (Figs. 6W, 7I–L; see Additional files
5,6,7,8) [31-33]. With the exception of activated Müller
glia (Fig. 7M–P; see Additional files 5,6,7,8), few of the
proliferating cells expressed markers of differentiated reti-
nal cells. It is important to point out that syntaxin, Pax6
and Chx10 are expressed in both retinal progenitor cells
and postmitotic differentiated cells. However, the combi-
nation of BrdU, Pax6, Chx10 and syntaxin immunoreac-
tivity combined with morphologic features of these cells
in electron micrographs lends support to their identifica-
tion as retinal progenitor cells.
In contrast to findings from a recent study [10], we did not
detect any defect in cone photoreceptor production in ret-
inal sections (Fig. 7Q, R) or in dissociated cells scored at
P0, P6, P12 or P30 (see Additional files 5,6,7,8). EM anal-
ysis of Chx10-Cre;RbLox/-; p107-/- retinas revealed immature
cells spanning all cellular layers of the retina (Fig. 7U, V).
These electron micrographs support the hypothesis that
Chx10+, Pax6+, BrdU+ cells in the ONL and INL are reti-
nal progenitor cells rather than differentiated cells. In
addition, real-time PCR analysis demonstrated an
increase in the expression of retinal progenitor cell mark-
ers in Chx10-Cre;RbLox/-; p107-/- retinas at P6, P12 and P30
(Fig. 6X, Y).
Our analysis of the Rb;p107-deficient retinas over the
course of postnatal retinal development showed that at all
stages of development studied, there are ectopically divid-
ing cells with morphologic features of retinal progenitor
cells that express markers of retinal progenitor cells. Our
data support the hypothesis that the role of reciprocal
compensation between Rb and p107 is to prevent deregu-
lated proliferation of retinal progenitor cells. If this is true,
then we would expect that inactivation of Rb and p107 in
a single proliferating retinal progenitor cell would lead to
clonal expansion.
We infected proliferating retinal progenitor cells in new-
born RbLox/-; p107-/- mice with the Cre-expressing retrovi-
rus LIA-Cre (Fig. 7W–Z). We observed significantly larger
clone sizes and changes in cell-fate specification (Fig. 7Y,
Z; see Additional file 9). To quantify the deregulated pro-
liferation, we used the NIN-Cre retrovirus, which
expresses nuclear lacZ and Cre, in E17.5 RbLox/Lox; p107-/-
retinas; NIN virus was used as a control. Clone size
increased and was consistent with deregulated retinal pro-
genitor cell proliferation. In control retinas infected with
NIN, 248 of 313 (80%) clones were one cell, and 11 of
313 (3.5%) contained more than two cells. In retinas
infected with NIN-Cre, 100 of 190 (52%) clones were one
cell, and 42 of 190 (24%) contained more than two cells
(Fig. 7AA). Similar results were seen in studies using the
E1A 13S oncogene [6,15].
Proliferation of progenitor cells and postmitotic transition 
cells in Rb;p107-deficient retinas
The developmental studies and clonal analyses described
above suggest that reciprocal compensation between Rb
and p107 prevents deregulated retinal progenitor cell pro-
liferation and retinoblastoma. However, we have shown
that p107 compensation also occurs at P3 when the
majority (93%) of cells are postmitotic (Fig. 5N). There-
fore, it is possible that reciprocal compensation betweenBMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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Rb and p107 prevents newly postmitotic cells from re-
entering the cell cycle rather than preventing deregulated
proliferation of retinal progenitor cells. To test this possi-
bility directly, we labeled all proliferating retinal progeni-
tor cells in P3 RbLox/Lox; p107-/- retinas with [3H]thy (Fig.
8A), inactivated Rb expression by electroporating a plas-
mid that expressed Cre and vYFP and then incubated the
retinas with BrdU. Cells that were BrdU+, vYFP+ and
[3H]thy+ were retinal progenitor cells at the beginning of
the experiment that continued to divide after acute Rb
inactivation. In contrast, cells that were BrdU+, vYFP+ and
[3H]thy- were postmitotic transition cells at the beginning
of the experiment that re-entered the cell cycle after acute
Rb inactivation. The time point P3 was selected because
the vast majority (~ 93%) of cells in the retina at that stage
are postmitotic [24]. If a postmitotic cell re-enters the cell
cycle after acute Rb inactivation in RbLox/Lox; p107-/- retinas,
then the majority of BrdU+ cells would be [3H]thy-. If a
retinal progenitor cell is more susceptible to deregulated
proliferation after acute Rb inactivation, then we would
predict that the majority of BrdU+ cells would be
[3H]thy+. If both retinal progenitor cells and postmitotic
cells divide after acute Rb inactivation, then the propor-
tions of BrdU+, [3H]thy- cells and BrdU+, [3H]thy+ cells
will reflect the proportions of postmitotic cells and
mitotic cells in the starting population, respectively.
Retinal progenitor cells are sensitive to deregulated proliferation after acute inactivation of Rb and p107 Figure 8
Retinal progenitor cells are sensitive to deregulated proliferation after acute inactivation of Rb and p107. (A) 
To determine if retinal progenitor cells are sensitive to deregulated proliferation after acute Rb inactivation in a p107-deficient 
genetic background, we labeled RbLox/Lox; p107-/- P0 or P3 retinas for 24 h with [3H]thy and then electroporated them with a 
Cre-venus-YFP plasmid. After 3 days in culture, the retinas were labeled for 1 h with BrdU and dissociated, and the YFP+ and 
YFP- cells were purified by FACS. (B-F) The cells were then analyzed by immunostaining, single-cell scoring and real-time PCR. 
(B, C) Colocalization of BrdU and [3H]thy demonstrated that most cells that continued to proliferate after Rb inactivation 
were retinal progenitor cells. (D) Real-time RT-PCR analysis confirmed that the proliferating cells expressed retinal progenitor 
cell markers. (E, F) Immunostaining and colocalization with [3H]thy further confirmed the retinal progenitor cell characteris-
tics of these cells. Scale bars: B and E, 10 µm.BMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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Most (79.8% ± 6%) ectopically dividing cells were BrdU+,
[3H]thy+ cells (Fig. 8B, C). Consistent with this finding,
results from real-time PCR and immunostaining analyses
revealed that ectopically dividing cells expressed several
retinal progenitor cell markers including Pax6,  Chx10,
Syntaxin, Erdr1 and Sfrp1 (Fig. 8D–F). However, there was
a small increase in the proportion of BrdU+, [3H]thy- cells
(Fig. 8C), which leaves open the possibility that either a
retinal progenitor cell or a transition cell is the cell of ori-
gin for retinoblastoma (discussed in [28]).
Discussion
We report here that in the developing mouse retina p107
is expressed in embryonic retinal progenitor cells, and Rb
is expressed in postnatal retinal progenitor cells. When
p107 is inactivated, Rb is upregulated in a compensatory
manner, and when Rb is inactivated, p107 compensates.
The p130 protein is expressed during the late stages of
retinogenesis and persists in the INL and GCL in the adult
retina. Rb and p130 are expressed redundantly in these
cells. There was no evidence of compensatory changes in
p130 expression following either Rb or p107 inactivation.
Compensation by p107 occurred when Rb was inactivated
acutely or chronically in the developing mouse retina.
Two copies of the p107  gene were required to prevent
deregulated proliferation of Rb-deficient retinal progeni-
tor cells, making p107 haploinsufficient for compensation
in the developing retina. In contrast, only one copy of Rb
was required to regulate proliferation of p107-deficient
retinal progenitor cells. We propose that reciprocal com-
pensation between Rb and p107 prevents deregulated
proliferation of retinal progenitor cells and retinoblast-
oma in mice. Similarly, redundant expression of Rb and
p130 may help to prevent retinoblastoma in mice.
In contrast to mice, human fetal retinal progenitor cells
primarily express RB1 during development. When RB1
was acutely inactivated in human fetal retinas, there was
little if any compensatory upregulation of p107. This may
explain why humans are susceptible to retinoblastoma
following RB1 gene mutations, but mice require inactiva-
tion of Rb and p107 or Rb and p130.
Overlapping and unique functions of the Rb family in the 
developing mouse retina
Immunostaining, in situ hybridization, real-time RT-PCR
and immunoblot analyses revealed that p107 is expressed
primarily in proliferating retinal progenitor cells of the
embryonic mouse retina. Pulse-labeling with [3H]thy
demonstrated that p107 is downregulated as cells exit the
cell cycle. There were no defects in cell-fate specification or
differentiation in p107-deficient retinas; thus, we propose
that p107 primarily regulates retinal progenitor cell prolif-
eration in the embryonic retina. Rb is expressed in postna-
tal retinal progenitor cells and differentiating neurons and
glia. Consistent with a role in cell-fate specification or dif-
ferentiation, Rb was expressed throughout the cell cycle
and continued to be expressed as cells entered G0. In the
absence of Rb, immature cells persist in the ONL and rod
photoreceptors failed to form, a finding that indicates that
Rb regulates the developmental processes in this specific
sublineage.
Recent studies have extended these findings by focusing
on the mechanism of Rb's role in rod development. Sun
and colleagues generated an exon-specific knock-in allele
of Rb with a single amino acid substitution (R654W) that
reduces Rb binding to E2F1, E2F2 and E2F3 [34]. In
Chx10-Cre;Rb654/Lox retinas, rods still fail to form. This
finding led to a model in which Rb regulates a rod repres-
sor gene through E2F1, E2F2 or E2F3, and in the absence
of Rb, the rod lineage is blocked. Moreover, we predict
that inactivation of the E2F that regulates this putative
"rod repressor" would rescue the rod developmental
defect. Preliminary data have shown that Rb;E2F1-defi-
cient retinas have normal rod development, a finding that
suggests that E2F1 is involved in this important develop-
mental process.
Our data suggest that Rb and p107 share the same role in
regulating mouse retinal progenitor cell proliferation but
the role of Rb is unique in rods. An extensive genetic anal-
ysis of p130 is beyond the scope of this manuscript, but
based on our expression studies and [3H]thy-labeling
experiments, we predict that Rb and p130 are redundant
in newly postmitotic cells of the INL and GCL. It is not
known if p130 is required for terminal cell cycle exit in the
developing retina, for maintaining cells in the postmitotic
state or both.
A recent study published by Spencer and colleagues char-
acterized the expression of the Rb family in developing
mouse retina and adult human retina [35]. Our data differ
from theirs, and we have presented the most relevant dif-
ferences in Figure 1. Our analysis combined several inde-
pendent methods (real-time RT-PCR, in situ
hybridization, immunostaining of tissue sections, immu-
nostaining of [3H]thy-labeled dissociated cells and immu-
noblotting); these approaches provided the same overall
picture of the dynamic changes in the expression of the Rb
family during seven stages of mouse retinal development.
Spencer and colleagues provided a more limited data set
with internal inconsistencies. For example, immunostain-
ing was done on samples from just three stages of mouse
retinal development (E14, P0 and P5), and in situ hybrid-
ization was carried out for Rb but not for p107 or p130.
Their real-time RT-PCR and immunoblotting data show
high levels of p107 expression in the embryonic retinas,
but no p107+ nuclei are detected in their immunostained
sections. Clearly, all expression data are limited by the rea-BMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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gents being used. For example, it is possible that the Rb,
p107 and p130 expression patterns in our study or that of
Spencer and colleagues are broader than reported due to
the limited sensitivity of the antibodies used. We have
attempted to minimize such limitations by combining
several independent approaches such as in situ hybridiza-
tion, immunostaining, real time RT-PCR and dissociated
cell staining. Nontheless, we anticipate that the retinal
expression pattern of the Rb family will be further refined
as new reagents become available.
Rb family redundancy and compensation in the developing 
mouse retina
The Rb family proteins are expressed in a dynamic manner
during mouse retinal development. We show here that
p107 is expressed in proliferating retinal progenitor cells
in the embryonic retina and is downregulated as cells exit
the cell cycle and undergo terminal differentiation.
Around birth, the expression of p107 tapers off, and that
of Rb takes it place in proliferating retinal progenitor cells.
Rb expression persists in postmitotic differentiating neu-
rons and glia of the mouse retina. The p130 protein is
expressed in the late postnatal period of mouse retinal
development. As cells exit the cell cycle, they upregulate
p130, and its expression persists in postmitotic differenti-
ating cells of the INL and GCL. Based on the expression
pattern alone, one might predict that proliferation would
be deregulated in p107-deficient embryonic retinas and
Rb-deficient postnatal retinas. However, we report here
that when p107 is inactivated, Rb is upregulated in a com-
pensatory manner in the embryonic retina. Similarly,
when Rb is inactivated, p107 is upregulated in a compen-
satory manner in the postnatal retina. There is no evi-
dence for compensation by p130 in either Rb- or p107-
deficient retinas.
One of the interesting features of the compensation that
we uncovered in this study is the haploinsufficiency of
p107 in this process. We show here that two copies of p107
are required for efficient compensation of Rb  loss, but
only one copy of Rb is required to compensate for p107
loss. This may indicate that there are different mecha-
nisms for Rb and p107 gene compensation or that retinal
progenitor cells exhibit different sensitivities to Rb and
p107 protein levels. One intriguing possibility is that p107
haploinsufficiency for compensation may reflect the dif-
ferential binding of Rb and p107 to different E2F family
members.
It has been shown previously that p107 is an E2F-respon-
sive gene; therefore, the mechanisms for p107 compensa-
tion most likely involve a direct feedback loop [36].
However, the mechanism for Rb compensation in the
absence of p107 has not been elucidated. We propose that
Rb-deficient retinal progenitor cells fail to form retino-
blastoma because p107 is upregulated in a compensatory
manner. However, it is possible that there is some over-
lapping, redundant expression around P0 in the develop-
ing mouse retina. Interestingly, Rb and p130 are expressed
redundantly in the INL and GCL. The recent observation
that retinoblastoma develops in Rb;p130-deficient retinas
suggests that redundant expression of these two Rb family
members prevents retinoblastoma in mice [11].
Previous studies using Rb-/- MEFs demonstrated that inac-
tivation of Rb in proliferating cells leads to compensatory
upregulation of p107 and quiescence after serum starva-
tion[20]. The p107 gene is persistently expressed in these
quiescent Rb-deficient MEFs and is required for maintain-
ing them in G0. When Rb was acutely inactivated in qui-
escent  RbLox/Lox  MEFs, p107 was not immediately
upregulated in a compensatory manner, and the cells re-
entered the cell cycle [20]. Therefore, chronic or acute
inactivation of Rb can lead to very different outcomes in
MEFs. The molecular changes that occur in MEFs as they
become quiescent have been compared with those that
accompany terminal cell cycle exit during development
[20]. However, in the developing CNS, postmitotic neu-
rons not only exit the cell cycle, but also migrate to their
appropriate layer, extend axons and dendrites and form
synaptic connections.
To test if there was any difference in p107 compensation
following acute versus chronic Rb  inactivation in the
developing retina, we developed genetic tools [16] to
acutely inactivate Rb in this context. Our data show that
p107 compensation occurs when Rb is inactivated acutely
or chronically in the developing retina. In addition, rod
photoreceptors failed to form when Rb was acutely inacti-
vated. These data suggest that p107 compensates for Rb in
proliferating retinal progenitor cells, but it cannot take the
place of Rb in differentiating rod photoreceptors.
We extended our acute inactivation studies to knock out
Rb in p107-deficient cells and to knock out p107 in Rb-
deficient cells. In these experiments, we compared the
effects of acute gene inactivation on proliferating retinal
progenitor cells and newly postmitotic transition cells.
The newly postmitotic Rb-deficient transition cells in
which p107 was acutely inactivated did not show exten-
sive ectopic cell division. These data are consistent with
the idea that p107 is important in regulating retinal pro-
genitor cell proliferation but not in preventing newly
postmitotic cells from re-entering the cell cycle. However,
a small subset of postmitotic cells still re-entered the cell
cycle following acute Rb inactivation in p107-deficient ret-
inas. Therefore, we cannot rule out the possibility that the
retinoblastoma cell of origin is a retinal transition cell
[28]. Definitive proof will rely on following the expansion
of clones lacking p107 and Rb to determine whether anyBMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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rare transition cells re-enter the cell cycle and expand to
generate retinoblastoma or if only retinal progenitor cells
continue to proliferate, as shown here [28].
Our data on the proliferation of Rb;p107-deficient retinal
cells during development contrasts with previous studies
by Chen and colleagues [10]. We show that ectopically
dividing retinal cells are present at P0, P6, P12 and P30,
whereas the previous study argued that proliferation
ceased at P30. This difference at P30 may be due to the
more sensitive and reproducible [3H]thy labeling we used
in our study compared to the BrdU labeling used by Chen
et al. Alternatively, it could reflect the non-cell-autono-
mous effect of broad Rb inactivation in Pax6-Cre;RbLox/Lox;
p107-/- retinas examined by Chen et al. compared with the
more restricted mosaic Rb inactivation in Chx10-Cre;RbLox/
-; p107-/- retinas that we investigated [16].
Another difference between our data and the study previ-
ously published by Chen and colleagues involves the
interpretation of the markers expressed in proliferating
cells of the Rb;p107-deficient retinas. We found that at P0,
the ectopically dividing cells were largely Pax6+ (see Addi-
tional file 5). By P6, the proliferating cells were Pax6+,
Chx10+ (see Additional file 6) and by P12, they were
Pax6+, Chx10+ and syntaxin+ (see Additional file 7). Pax6
[32] and syntaxin [31] are expressed in both retinal pro-
genitor cells and differentiating amacrine cells. Chx10 is
expressed in retinal progenitor cells and in differentiated
bipolar cells and Müller glia [29]. Interestingly, at P12 we
noted that GFAP+ Müller glia were also [3H]thy+. This
finding is consistent with proliferation associated with
reactive gliosis in Rb;p107-deficient retinas [30]. Chx10
immunopositivity may mark the proliferating Müller glia,
bipolar cells or progenitor cells at this stage. However, we
do not believe that the Chx10+ cells are bipolar cells,
because there were no PKCα+ cells that incorporated
[3H]thy at P12. At P30, most of the proliferating [3H]thy+
cells were syntaxin+. A smaller proportion were Pax6+,
recoverin+ and PKCα+. Recoverin is expressed in a subset
of bipolar cells as well as photoreceptors, so the PKCα+
and recoverin+ cells that incorporated [3H]thy are most
likely a small cohort of bipolar cells that re-entered the
cell cycle.
Based on the timeline of marker colocalization with
[3H]thy that we present here, we propose that a Pax6+,
Chx10+ and syntaxin+ retinal progenitor cell population
that is biased toward the amacrine/horizontal cell fate
continues to proliferate through development in Chx10-
Cre;RbLox/-; p107-/- retinas and eventually gives rise to retin-
oblastoma. This model is consistent with the extensive
differentiation of mouse retinoblastomas along amacrine/
horizontal cell lineage (Johnson and Dyer, in prepara-
tion). There is an occasional round of ectopic prolifera-
tion in reactive Müller glia and possibly bipolar cells at
P30, but based on the absence of glial and bipolar markers
in mouse retinoblastomas, we propose that these cells do
not contribute significantly to retinoblastoma in mice.
Chen and colleagues [10] showed that Pax6+, Chx10+,
Prox1+, Math3+, Crx+ and Hes5+ cells incorporated
BrdU. With the possible exception of Crx, each of these
markers is expressed in both progenitor cells and differen-
tiated cells [18,32,33,37-42]. We have found that several
additional retinal progenitor cell markers (syntaxin 1,
Fgf15, Sfrp1, Erdr1 and Eya2) are expressed in proliferat-
ing cells of Rb;p107-deficient retinas. Overall, 10 of the 11
genes that are expressed in proliferating Rb;p107-deficient
retinal cells have one feature in common; they are all
expressed normally in retinal progenitor cells. The mor-
phological features of the Rb;p107-deficient retinal cells in
electron micrographs are also consistent with retinal pro-
genitor cells. While these data support the hypothesis that
retinal progenitor cells continue to divide during develop-
ment of Rb;p107-deficient retinas and eventually give rise
to retinoblastoma in mice, marker expression alone can-
not distinguish between a progenitor cell and a transition
cell as the cell of origin for retinoblastoma (discussed in
[28]). Definitive proof of the cell of origin for retinoblas-
toma will require clonal analysis of tumor formation from
a single cell in vivo.
Retinoblastoma susceptibility in mice and humans
When the Rb-knockout mouse was generated over 13
years ago, it was expected that retinoblastoma would
develop in Rb+/- mice, as it does in RB1+/- humans. How-
ever, that was not the case. We show here that the normal
expression of Rb family members is dynamic during
mouse retinal development and that reciprocal compen-
sation between Rb and p107 may prevent retinoblastoma
in mice.
In the human fetal retina, RB1 is the major family mem-
ber expressed during much of retinal development. There
is little or no expression of p107. We acutely inactivated
RB1 in primary human fetal retinas by electroporating an
SiRNA to RB1. We demonstrated that although the RB1
protein was downregulated 20-fold, there was no com-
pensation by p107 or p130. These data suggest that
humans are susceptible to retinoblastoma formation after
RB1 inactivation, because they cannot upregulate p107 in
a compensatory manner. It is possible that the 20-fold
reduction in RB1 protein induced by the SiRNA used for
these experiments is not sufficient to induce p107 com-
pensation. However, we do not believe this is the case
because another RB1 target gene (p14ARF) is induced by
10-fold following acute RB1 inactivation using the same
SiRNA (Laurie et al., submitted). One possible explana-
tion for the lack of compensation in the human retina isBMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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that the p107 promoter is sequestered in an inactive chro-
matin conformation in human fetal retina, but it is in an
active chromatin conformation in mouse retinal progeni-
tor cells and is thus poised to respond to a loss of Rb.
Indeed, it is believed that promoters and genes that have
been recently transcribed remain in an active chromatin
configuration. Therefore, this model is consistent with the
expression data for mouse and human p107. That is, the
embryonic expression of p107 in the mouse retina results
in an open chromatin conformation, thereby making it
readily accessible for compensatory upregulation if Rb is
inactivated. Detailed promoter and transcription analyses
will be required to test this hypothesis.
Conclusion
We have found that Rb and p107 are expressed in a largely
non-overlapping pattern during mouse retinal develop-
ment and that reciprocal compensation between these
two Rb family members prevents retinoblastoma in mice.
p107 compensation occurs whether Rb is inactivated
chronically or acutely. In human retinal development,
there is very little p107 expressed and compensation does
not occur when RB1 is inactivated using an siRNA. We
propose that this difference in compensation between
mice and humans may explain why humans are suscepti-
ble to retinoblastoma following RB1 gene inactivation but
mice require simultaneous inactivation of the Rb  and
p107 genes.
Our data also shed light on the retinoblastoma cell of ori-
gin. Proliferating retinal progenitor cells are dispropor-
tionately more susceptible to deregulated proliferation
following  Rb;p107  gene inactivation in comparison to
newly postmitotic transition cells [28]. Consistent with
this observation, 10 of 11 genes expressed in proliferating
Rb;p107-deficient retinal cells are normally expressed in
retinal progenitor cells. Electron micrographs of Rb;p107-
deficient retinal cells provides further support for an
immature cell with features of progenitor cells as the retin-
oblastoma cell of origin. However, based on our data, it
remains a formal possibility that a postmitotic amacrine
or horizontal cell is the retinoblastoma cell of origin.
Ongoing lineage studies should help to determine if a
progenitor cell, a postmitotic neuron or both can give rise
to retinoblastoma in mice.
Methods
Mouse strains
Rb+/- mice were obtained from The Jackson Laboratory
(Bar Harbor, ME), and RbLox/Lox mice were obtained from
the National Cancer Institute. The p107-knockout mice
were obtained from Dr. Tyler Jacks (MIT). Chx10-Cre mice
were obtained from Dr. Connie Cepko (Harvard Medical
School). All mice were crossed to C57Bl/6 mice purchased
from Charles River Laboratories (Wilmington, MA). The
St. Jude Children's Research Hospital Institutional Animal
Care and Use Committee approved all of the animal
experiments.
Antibodies, immunostaining, BrdU, [3H]thymidine and 
TUNEL studies
We immunolabeled retinal cryosections from mice of var-
ious genotypes (p107-/-, p107+/-, p107+/+) at various post-
natal stages (P3, P6, P12 and adult) and dissociated
retinas (500 cells per sample in triplicate) as previously
described [22,43]. The list of antibodies used is provided
(Supplementary Table 9). To label S-phase retinal progen-
itor cells, we incubated freshly dissected retinas in 1 ml
explant culture medium containing [3H]thy (5 µCi/ml; 89
µCi/mmol) or 10 µM BrdU for 1 h at 37°C. For these
pulse-labeling experiments, retinas were dissected at four
stages of development (E14.5, E17.5, P0, and P2) and
exposed to the label for various durations (0, 4, 8, 16 and
24 h) to allow retinal progenitor cells to progress through
the cell cycle. The p27Kip1 protein, which is upregulated at
G1/G0, was used as an internal control (Fig. 2D, H, L),
because its expression during retinal development has
been characterized previously [2,22,23].
Autoradiography and BrdU detection were carried out as
described previously [22,43]. For apoptosis analysis, we
sectioned (14-µm) retinas on a cryostat. We used the
colorimetric TUNEL apoptosis system (Promega, Madi-
son, WI) per the manufacturer's instructions; however, for
detection, we used tyramide-Cy3 (Perkin-Elmer, Welles-
ley, MA) rather than the colorimetric substrate.
Electroporation and FACS
Retinas were electroporated in vivo at P0 by injecting 0.5
µl CsCl preparation plasmid DNA (5 µg/µL) into the eye.
Electroporation consisted of five 50-µsec pulses of 80 V
each separated by 950-µsec recovery periods. As a control,
retinas were electroporated with a plasmid lacking Cre.
For explant cultures, the DNA was purified and resus-
pended in HBSS at 1 µg/µL.
Electroporation consisted of five pulses of 25 V for 50 µsec
each with 950-µsec recovery periods. For FACS purifica-
tion of electroporated cells, retinas were dissociated as
described previously [22,43], resuspended in explant cul-
ture medium and sorted using vYFP fluorescence on a Bec-
ton-Dickson FACS system (Rockville, MD).
Real-time RT-PCR
Real-time RT-PCR experiments were performed using the
ABI 7900 HT Sequence Detection System (Applied Biosys-
tems, Foster City, CA). Primers and probes were designed
using Primer Express® software (Applied Biosystems). Taq-
Man® probes were synthesized with 5'-FAM and 3'-BHQ.
RNA was prepared using Trizol, and cDNA was synthe-BMC Biology 2006, 4:14 http://www.biomedcentral.com/1741-7007/4/14
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sized using the Superscript system (Invitrogen, Carlsbad,
CA). Samples were analyzed in duplicate and normalized
to Gapdh, Gpi1 and Mmt2 expression levels.
In situ hybridization and immunoblot analyses
For immunoblot analysis, retinas of C57Bl/6 mice were
dissected at the following seven stages of development:
E14.5, E17.5, P0, P3, P6, P12 and adult. Retinas were son-
icated in RIPA with protease and phosphatase inhibitors
(Sigma, St. Louis, MO) to clear the lysate. The debris was
pelleted, and the concentration of each lysate was deter-
mined using a Bradford assay (BioRad Laboratories, Her-
cules, CA). Lysate (30 µg) was loaded onto each lane and
transferred to nitrocellulose. Each antibody was used at a
dilution of 1:1000, and HRP-conjugated secondary anti-
bodies were used at 1:5000. The Amersham ECL system
(Piscataway, NJ) was used to detect antibody binding per
the manufacturer's instructions. For in situ hybridization,
retinas from each stage of development were rapidly dis-
sected, fixed for 1 h in 4% paraformaldehyde, cryopro-
tected in 30% sucrose/PBS and embedded in OCT before
freezing on dry ice. Cryosections (14-µm thick) were cut,
mounted on slides and dried. Tissue was rehydrated in
and treated briefly with proteinase K. Slides were then
acetylated in acetic anhydride/0.1 M TEA and dehydrated
using an alcohol series. Prehybridization was carried out
with formamide/SDS hybridization solution, and the
riboprobes were added (33P-labeled or DIG-labeled
probes at the same specific activity and total mass).
Hybridization was carried out at 60°C overnight, and the
slides were washed in a series of SSC washes. The sections
were then counterstained with a nuclear dye (Sytox green
or PI) and dehydrated prior to immersion in autoradio-
graphic emulsion. Exposure was carried out for 1 week
before the blots were developed.
Human fetal retinal cultures
Human fetal eyes were provided by ABR, Inc. (Alameda,
CA). Eyes were transported in RPMI medium on wet ice.
Retinas were isolated and divided into 8 radial sections.
Each section was placed on a polycarbonate filter and
maintained in explant culture medium, as described pre-
viously for mouse retinas [22,25,37]. BrdU labeling,
[3H]thy labeling, dissociation and FACS were carried out
as described above for mouse retinas. These experiments
were reviewed and approved by the St. Jude Children's
Research Hospital Institutional Review Board.
Microscopy
Bright-field and single-cell fluorescent images were
obtained using a Zeiss Axioplan-2 fluorescent microscope
with the Zeiss AxioCam digital camera. Fluorescent
images of tissue sections were obtained using a Leica
TCSNT confocal microscope. For EM, animals were anes-
thetized with avertin until a loss of deep tendon reflexes.
Transcardial perfusion was performed with carboxygen-
ated Ames Medium supplemented with 40 mM glucose to
clear the vasculature, followed by perfusion with Soren-
son's phosphate buffer (pH 7.2) containing 2% EM-grade
paraformaldehyde and 1% EM-grade glutaraldehyde. Eyes
were then harvested; a slit was made in the cornea to aid
in diffusion; and the tissue was placed in 3% glutaralde-
hyde in Sorenson's phosphate buffer overnight. Tissue
was washed with 0.2 M cacodylate buffer in 5% sucrose,
post-fixed in 1% OsO4, embedded, sectioned and viewed
by transmission EM.
Retroviruses and retinal cultures
Retroviruses and retinal culture procedures have been
extensively described elsewhere [22,37,43].
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